What's New
Potential impurity in ranitidine formulationsOctober 1, 2019
Medicines containing ranitidine have been recalled by some overseas regulatory authorities because of nitrosamine contamination. Nitrosamine is potentially carcinogenic. Medsafe have taken a more conservative approach and not yet made any recalls. However, GlaxoSmithKline (NZ) Ltd has issued a medicine level recall (pharmacy level only) effective 30/9/19 of all Zantac Injection 50mg/2mL and put a […]
Withdrawal of dosulepin (dothiepin) and doxepin from New ZealandJuly 18, 2019
Two tricyclic antidepressants (TCAs), dosulepin (dothiepin) and doxepin will no longer be available in New Zealand. When transitioning patients to alternatives, consider: Is a TCA still appropriate? TCAs are associated with a higher risk of adverse outcomes in people with cardiovascular disease and older adults. Individual psychiatric history. Switching therapy increases the risk of relapse […]
